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Would You Recognize Lupus?
Barbara Brown, Maegan Simms, BS, and Sydney Smith
Dental Hygiene Program at Virginia Commonwealth University

Abstract
Systemic Lupus Erythematosus, or SLE, is a chronic
autoimmune disease which significantly affects various
organs of the body and the oral cavity. According to
various studies, SLE can cause an increased risk of
periodontitis, fungal infections, and dental caries within the
oral cavity. Periodontitis is an inflammatory condition
mediated by an infectious etiology which affects the
supporting tissues of the periodontium and alveolar bone.
With SLE being an inflammatory condition as well, recent
studies have emerged hypothesizing the possible
association between SLE and periodontitis. Other effects
on the oral cavity such as fungal infections including lichen
planus and angular cheilitis are occasionally seen in
patients with lupus. Furthermore, SLE has been shown to
increase the prevalence of dental caries due to decreased
salivary flow and pH, and subsequent changes in the oral
flora. On a systemic level, internal inflammation of SLE
could lead to several other problems within the body and
certain medications patients take for SLE treatment can
cause cutaneous lesions. Therefore, as clinicians, it is
imperative to adequately review patient medical histories
as well as perform intraoral and extraoral examinations in
order to fully understand the possible contraindications
between dental treatment and SLE.

Introduction
The purpose of this literature review is to inform clinicians
on the oral and systemic aspects of SLE and how
evidence-based decision making may impact dental
treatment planning in order to provide patients with the
best quality of care.

SLE and the Oral Cavity
Systemic Lupus Erythematosus, or SLE, is a chronic
autoimmune inflammatory disease affecting the central
nervous system, the heart, lungs, kidneys and skin. Some
of the most common symptoms seen with this disease
include the malar, or butterfly, rash, joint pain and swelling,
loss of appetite, nausea, etc. The etiology of SLE is not
completely known, but this autoimmune disease is more
prevalent among women of child bearing age. Since there
is no cure for SLE, the goal of treatment is to relieve
symptoms and protect organs by decreasing internal
1
inflammation.

Review of Literature
SLE and Periodontitis
In a recent study, an analysis was done comparing the
frequency and severity of chronic periodontitis between SLE
patients and non-SLE patients. After measuring plaque index,
BOP, probing depths, and attachment levels on both groups,
the researchers determined the severity of periodontal disease
was about the same, but chronic periodontitis occurred at an
2
earlier age in SLE patients.
In another study, researchers found a significant elevation in
anaerobic bacteria such as Prevotella, Selenomonas, and
Treponema, in SLE patients by extracting DNA from endodontic
paper points placed in their deepest pockets. A positive
correlation has been found between SLE patients and the “red
3
complex” periodontal pathogens as well.

Fig. 1. Possible mechanisms associating Toll-like receptor
with systemic lupus erythematosus and periodontal
disease.11

Fig 1. Distribution of 75 SLE patients and
75 control subjects with an without chronic
periodontitis according to age.2

SLE and Fungal Infections
SLE patients may experience angular cheilitis, with severe
4
crusting around their lips which is most often asymptomatic. It
is possible for patients to present with erosive lichen planus as
well with the most common areas being the buccal mucosa,
5
hard palate, and lower lip. Invasive fungal infections as a whole
serve as a major problem for these patients, causing an
6
increased risk of mortality and increased hospital readmission.

SLE on a Systemic Level
SLE has the potential to cause serious organ
inflammation throughout the body including the muscles,
blood vessels, and the lining of the lungs and kidneys. In
addition to internal inflammation, there is a risk of
leukopenia and thrombocytopenia, causing an increased
1
risk of infection and bleeding respectively. There are
potential adverse effects from prolonged use of a
specific SLE medication Hydroxychloroquine, or HCQ,
8
one effect being cutaneous lesions. Along with this,
another adverse effect of HCQ is hyperpigmentation of
9
the lips and gingiva.

Conclusion
As clinicians it is pertinent to thoroughly review over
medical histories, perform adequate extraoral and
intraoral examinations, and provide the best quality of
care for patients suffering with SLE. Intraoral
examinations are of particular importance due to oral
ulcerations being present in about 9-45% of SLE
patients and xerostomia being likely if the disease
10
affects the salivary glands.
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Abstract
Systemic Lupus Erythematosus, or SLE, is a chronic autoimmune disease which significantly
affects various organs of the body and the oral cavity. According to various studies, SLE can
cause an increased risk of periodontitis, fungal infections, and dental caries within the oral
cavity. Periodontitis is an inflammatory condition mediated by an infectious etiology which
affects the supporting tissues of the periodontium and alveolar bone. With SLE being an
inflammatory condition as well, recent studies have emerged hypothesizing the possible
association between SLE and periodontitis. Other effects on the oral cavity such as fungal
infections including lichen planus and angular cheilitis are occasionally seen in patients with
lupus. Furthermore, SLE has been shown to increase the prevalence of dental caries due to
decreased salivary flow and pH, and subsequent changes in the oral flora. On a systemic level,
internal inflammation of SLE could lead to several other problems within the body and certain
medications patients take for SLE treatment can cause cutaneous lesions. Therefore, as
clinicians, it is imperative to adequately review patient medical histories as well as perform
intraoral and extraoral examinations in order to fully understand the possible contraindications
between dental treatment and SLE. The purpose of this literature review is to inform clinicians
on the oral and systemic aspects of SLE and how evidence-based decision making may impact
dental treatment planning in order to provide patients with the best quality of care.

Introduction

Systemic Lupus Erythematosus, or SLE, is a chronic autoimmune inflammatory disease
which significantly affects various organs of the body and the oral cavity.1 SLE is the systemic
form of lupus and directly affects multiple areas in the body, including the central nervous
system, the heart, lungs, kidneys, and the skin. With SLE being categorized as an autoimmune
disease, this complex and potentially severe condition attacks healthy cells, tissues, and organs,
resulting in chronic inflammation. There is no cure for systemic lupus erythematosus at the
present time. However, the goal of treatment is to relieve the symptoms of the disease and
protect internal organs by decreasing the amount of inflammation within the body. Common
symptoms of people suffering from SLE include joint pain and swelling, loss of appetite, nausea,
muscle aches, and severe fatigue. Most people suffering from SLE will develop arthritis during
the course of the disease, and this form of arthritis mimics another autoimmune disease known as
rheumatoid arthritis.2 However, the most notable symptom of people with lupus in general is the
skin rash over the nose and cheeks termed the malar rash, otherwise known as the butterfly rash.
This non painful rash can be precipitated or even worsened by a process called photosensitivity,
or exposure to sunlight. Photosensitivity could even cause what’s called a “flare” of SLE, which
is characterized by increased inflammation throughout the body.2 In addition to the malar rash,
other areas of the skin exposed to sunlight can be susceptible to a rash too.3
The etiology of SLE is not completely known but some suggest it may be related to
genetic, environmental, or hormonal factors. The strongest risk factor of this disease is gender,
with SLE being more prevalent among women of child-bearing age between age 20 to 45, and a
male to female ratio of 1:8.2 Certain people are more at risk than others in developing SLE
including people of African American, Hispanic, and Asian descent.3 Due to the ability to detect
lupus at earlier stages, the incidence of lupus has significantly increased over the past 40 years.4

On a broad scale, there are approximately 16,000 new cases of lupus are diagnosed every year
and five million people suffer from this disease worldwide. Unfortunately there is no single test
to diagnose SLE, so in order to diagnose someone with this condition, one has to rule out other
autoimmune diseases with the same symptoms such as rheumatoid arthritis.3
Luckily, the American College of Rheumatology has developed eleven specific criteria in
order to effectively diagnosis people with SLE. Along with rheumatologists, neurologists,
immunologists, etc., oral health care professionals are an additional key asset to this
interprofessional group due to the oral manifestations seen in patients with SLE.2 Due to the
numerous effects systemic lupus erythematosus can have on the body, the purpose of this
literature review is to inform clinicians on the oral and systemic aspects of SLE and how
evidence-based decision making may impact dental treatment planning in order to provide
patients with the best quality of care. All of the studies and additional information discussed in
this review of literature were primarily found on PubMed and serve to backup all of the claims
regarding SLE and its effects on the oral cavity and the body as a whole.

SLE and Periodontitis

In regards to SLE and its effects on the oral cavity, many studies have shown a possible
association between systemic lupus erythematosus and periodontitis. Periodontitis is an
inflammatory condition mediated by an infectious etiology which affects the supporting tissues
of the periodontium and alveolar bone. The accumulation of dental plaque initiates gingival
inflammation, leading to anaerobic bacterial colonization and loss of periodontal attachment and
possible tooth loss. Certain bacteria known as the “red complex” organisms serve as the
infectious etiology of periodontitis, which include Porphyromonas gingivalis, Tannerella
forsythia, and Treponema denticola.1 This subgingival microbiota increases the severity of the

periodontal disease as well as local inflammation.5 With SLE being an inflammatory condition
as well, recent studies have emerged hypothesizing the possible association between SLE and
periodontitis.
In fact, the prevalence of periodontitis in patients with SLE varies, ranging from 60 to
about 93.8%. In a recent study, an analysis was done to compare the frequency and severity of
chronic periodontitis between seventy-five patients with SLE to seventy-five patients without
SLE or any rheumatic disease. They measured plaque index of all patients and various indicators
of periodontal disease including probing depth, clinical attachment level, and bleeding on
probing. Out of the seventy-five patients in the group with SLE, fifty-one of them had chronic
periodontitis and forty-one of the seventy-five people without SLE had chronic periodontitis.
The severity of the disease in both groups was about the same, however, chronic periodontitis
occurred earlier for patients with SLE. Overall, the likelihood of developing chronic periodontitis
was systematically higher for the patients with SLE, especially at younger ages.6
Similar to this study, a systematic review and meta-analysis was conducted using various
publications to determine another possible association between periodontitis and systemic lupus
erythematosus. A total of 1,383 patients were studied, with 487 having SLE and 896 without
SLE. These patients were observed in multiple observational studies of cross-sectional, casecontrol, or cohort design. After doing a meta-analysis, the researchers found the overall risk of
contracting periodontitis in SLE patients was significantly greater than patients without SLE with
a risk ratio of 1.76. However, this study did not find any significant association in regards to the
specific indicators of periodontitis including pocket depth, clinical attachment loss, or bleeding
on probing. From these results, the researchers concluded further longitudinal studies need to be
conducted to actually confirm the association between SLE and periodontitis.1

Research has shown periodontal treatment can reduce the symptoms of SLE by reducing
the expression of Toll-Like Receptors (TLRs). TLRs are sensing proteins of the innate immune
system which trigger the inflammatory response to bacterial invasion.7 Studies have shown
significant elevations in anaerobic bacteria such as Prevotella, Selenomonas, and Treponema in
patients with SLE. In a recent study, the subgingival microbiota was measured in both SLE
patients and healthy subjects to determine if there is a link between periodontal disease and SLE.
Researchers found a significant elevation in anaerobic bacteria in SLE patients while there was
an increase in abundance of aerobic bacteria in non-SLE patients. This was achieved by placing
endodontic paper points into sites with the deepest pockets for one minute each. DNA was then
extracted from the samples and sequenced. Positive correlations were found between SLE
patients and the “red complex” periodontal pathogens T. denticola, P. gingivalis, and T.
forsythia.6

SLE and Fungal Infections

In addition to an increased risk of periodontitis, patients with SLE may experience fungal
infections such as angular cheilitis, lichen planus, and invasive fungal infections as a whole. SLE
patients with angular cheilitis will commonly experience severe crusting around their lips, often
times being painless. These mucocutaneous lesions can present themselves in a variety of ways
including keratotic, bullous, or varrucous lesions.8 Furthermore, about 45% of patients with SLE
have oral mucosa involvement including erythema in multiple sites. Although less common than
erythemic sites, it is possible for SLE patients to present cases of fungal infections such as
erosive oral lichen planus.9 The most common areas for lesions include the buccal mucosa, hard
palate, and lower lip.8

Invasive fungal infections as a whole prose a major problem for patients with SLE, with
infections of the respiratory and urinary tracts, and blood causing about 30% of deaths. With an
increased risk of mortality and a higher prevalence of hospital readmission, these infections tend
to worsen patient prognosis and are associated with patients who have a greater disease severity.
In order to determine the commonness and risks associated between invasive fungal infections
and SLE, a cross-sectional study was conducted among Colombian patients with systemic lupus
erythematosus. This study included two-hundred subjects and was conducted over a six year
period with 84.5% of the patients being women with the median age being thirty-six years old.
There was a median diagnosis of forty-one months, with medications and comorbidities of the
patients recorded in the beginning of the study. In result, fifteen patients presented with invasive
fungal infections. The researchers in this study found Candida albicans being the most
frequently isolated fungal microorganism, followed by Candida tropicalis, predominantly found
in blood sites. Other fungal microorganisms found in this study include Histoplasma
capsullatum, Candida glabrata, and Cryptococcus neoformans. When referring to the increased
risk of mortality, patients with SLE who suffered from invasive fungal infections as well had a
9.91 times higher risk of mortality than SLE patients without these fungal infections.10

SLE and Dental Caries

Not only does SLE have an association with periodontitis and fungal infections, this
disease in fact has an association with an increased prevalence of dental caries as well. Dental
caries is the most prevalent oral disease, affecting people from all over the world. There are
several risk factors associated with dental caries, with these factors being assessed in patients
with SLE in a current observational cross-sectional blind study. Some specific dental caries risk
factors researchers assessed during this study included salivary flow, pH, buffer capacity, and

presence of cariogenic bacteria. The frequency of dental caries were assessed among 60
participants with SLE, either in active or inactive forms of SLE, divided equally into two groups
of 30 subjects each. Two indexes were used in this study to analyze dental caries including the
decayed, missing, and filled teeth, or DMFT index, and the Integrative Dental Caries Index, or
IDCI.11
The researchers of this cross-sectional study found a strong positive correlation between
active SLE patients and the specific risk factors for dental caries including a decrease in salivary
flow, a change in oral pH, and the quantity of cariogenic bacteria, such as Streptococcus mutans
and Streptococcus sobrinus. The two factors with the most vital role in the high caries activity of
patients with lupus included salivary flow and pH. In active SLE, those patients had a more
substantial decrease in salivary flow and a significantly more acidic salivary pH. Moreover, the
researchers determined most patients who suffer with SLE suffer from certain oral complaints as
well which are associated with a decrease in salivary flow, with the prevalence in this study
being 85%.11

SLE on a Systemic Level

On a more systemic level, with SLE being an inflammatory condition, some serious
organ inflammation could occur in the brain, liver, and kidneys. There is a potential for
leukopenia, or a decrease in white blood cell count, and thrombocytopenia, or low platelet count,
in patients with SLE. The risk of both leukopenia and thrombocytopenia involves an increased
risk of infection and an increased risk of bleeding, respectively. Other areas prone to
inflammation within the body seen in SLE patients include muscles, blood vessels, the lining of
the lungs, and kidneys. When lupus starts to involve the brain, this could lead to personality
changes, possible seizures, and nerve damage.2

In terms of treatment for SLE, certain medications patients take can cause cutaneous
lesions and possibly contribute to development of periodontal disease prematurely. Treatment
of SLE is primarily directed toward decreasing the amount of inflammation or the level of
autoimmune activity with certain anti-inflammatory drugs for people with mild symptoms, and
corticosteroids tend to be used for people with more severe forms of SLE.2 In regards to specific
medications patients with SLE might take, recent studies showed a high correlation between the
presence of pathogens like Fusobacterium and P. gingivalis and the dosage of prednisone.5
Furthermore, in some patients cutaneous lesions could result, either from taking
Hydroxychloroquine (HCQ), an antimalarial drug used to treat SLE, as a result of increased
disease.12 Medication cessation should be completed with a referral to a dermatologist to
determine the cause of lesions. The cause of the reaction due to HCQ is unknown and may be
due to the imbalance of the immune system in the early initiation of the drug. The
recommendations by the dermatologist can vary depending on the severity of cutaneous lesions
and whether or not the reaction has an effect on the systemic condition of the patient.12 Another
adverse effect of HCQ can be hyperpigmentation on the lips and gingiva after a long duration of
medication intake. A cross-sectional study of forty-one patients was conducted to determine the
possibility of hyperpigmentation in systemic disease. Of the forty-one cases, 73.2% of them were
prescribed the hydroxychloroquine to treat SLE. After thirty-two months of hydroxychloroquine
treatment pigmented lesions were noted in the lower limbs, face, lips, and gingiva of the SLE
patients. Only the SLE patients who participated in this study presented with
hydroxychloroquine hyperpigmentation, which suggests hydroxychloroquine pigmentation may
be more frequent in SLE patients than in other diseases.13

Conclusion
As clinicians, it is imperative to adequately review patient medical histories as well as
perform extraoral and intraoral examinations in order to fully understand the possible
contraindications between dental treatment and SLE. Upon discovering the presence of SLE in a
patient, it is important to understand the increased risk of myocardial infarction to help prevent
medical emergencies. According to a cross-sectional study, an increase of endothelial
microparticles is found in SLE patients. Endothelial microparticles trigger neutrophil activation
and coagulation which in turn triggers inflammation causing endothelial vascular issues which
may lead to myocardial infarction.14 It is important for a clinician to be well versed in the
medications these patients are taking for SLE and whether there is a need for possible medication
cessation. Equally important to adequately reviewing over SLE patient’s medical history, it is
obligatory to efficiently complete an extra-oral examination as well to find possible cutaneous
lesions, and hyperpigmentation caused by SLE medications.12 Similar to providing extra-oral
examinations, intra-oral examinations are an additional necessity for these patients considering
oral ulcerations may be present, and are in fact present in nine to forty-five percent of the people
suffering from lupus according to the European Journal of Dermatology. However, the initial
diagnosis of these oral ulcerations may require a biopsy and collaborate work with a
rheumatologist to determine whether or not these ulcerations are caused from lupus itself.
Another important thing to keep in mind as clinicians when it comes to lupus is some patients
might experience xerostomia if it affects their salivary glands, so providing fluoride varnishes to
these patients might be a necessity and they could be at a higher caries rate compared to other
patients.3

A recent study investigated the oral health quality of life in patients with SLE.
Researchers found patients with SLE have a lower oral health quality of life mainly due to the
increased need for oral prosthesis wearing. Due to the increased periodontal bone loss in these
patients, it is fairly common among patients with SLE to lose teeth and require partial dentures.
Studies have shown an increase in mouth sores and ulcers due to ill-fitting dentures, thus
lowering their quality of life.15 It is important to recognize and understand all of the effects of
SLE on the oral cavity and the entire body in order to provide the best quality care for patients
living with this autoimmune inflammatory disease.
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